Replies to post #8053 on Arch Therapeutics Inc (ARTH)

[forever39]

Hi GrosPied, I'm also very concerned. I've been with arth for over 3 years and am holding onto my shares for now. But, I'm very concern about Norchi's ability to get the FDA issues resolved. His staff, past and present, has a poor track record per CE and getting clinical trials completion. I really feel that Norchi needs to demonstrate in a very timely manor he can get AC5 moving. I think he is running out of time.